Table 1. Baseline Characteristics of the Study Population, Data Are Expressed as Mean ± Standard Deviation, Except Where Otherwise Noted.
| Characteristics | Patients with chronic hepatitis C (CHC) | Healthy Controls |
|---|---|---|
| Subjects enrolled, No. | 60 | 65 |
| Age, y, Mean ± SD | 47.4 ± 9 | 48.3 ± 13 |
| BMI, kg/m2, Mean ± SD | 26.3 ± 2.1 | 27.7 ± 3.1 |
| Gender: Male/Female, No. | 39/21 | 37/28 |
| ALT, IU/L, Mean ± SD | 79.4 ± 18 a | 12.6 ± 8 a |
| HCV RNA, IU/ml × 103, Mean ± SD | 516 ± 160 | - |
| Genotype 1b, No. | 60 | - |
| METAVIR fibrosis stage | ||
| F1, No. | 13 | - |
| F2, No. | 20 | - |
| F3, No. | 20 | - |
| F4, No. | 7 | - |
| METAVIR activity grade | ; | |
| A0, No. | 9 | - |
| A1, No. | 13 | - |
| A2, No. | 22 | - |
| A3, No. | 16 | - |
aPatients with CHC vs. Healthy Controls: P < 0.01